🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I'm honored to be part of the inaugural Global Oncology trainee track Memorial Sloan Kettering Cancer Center & grateful for our conversation w Selwyn M. Vickers Thankful for @DrPeterKingham & Dr Victoria Mango & my inspiring cofellows Drs @SaraMoufarrij1 Ya Haddy Sallah Fatemeh Parvin-Nejad Layal Al Mahmasani

To all my Filipino friends out there, happy #PhilippineIndependenceDay! Erin Feliciano, MD, MBA Edward Christopher "Chris" Dee, MD Trisha Santos, MD, MS Roselle De Guzman James Wu | 吴简凡 MD

#ProstateCancer Disparities: A Global Lens. #RadiationOncologist Edward Christopher "Chris" Dee, MD Memorial Sloan Kettering Cancer Center joins Andrea Miyahira Prostate Cancer Foundation to discuss a Nature Reviews Urology publication, emphasizing that equal access to quality care can mitigate and even reverse disparities, as shown in VA and clinical

Group performs Beethoven’s symphony No.5 a cappella [🎼 HotPlaysMusic]

So proud of our team’s effort on tackling the issue of hemophilia care in the SEA region! 🩸

📜 In @ThyroidJournal led by Justin Choi & Dr @IMRTLee, we present long-term results of #EBRT w/wo concurrent #chemo in #patients w differentiated #thyroid #cancer ☢️ In pts w adv DTC w/o surgical options, CRT did not improve outcomes over #RT alone 🔗 pubmed.ncbi.nlm.nih.gov/40504742/

🚨In The Lancet, Edward Christopher "Chris" Dee, MD & I discuss the need to disaggregate #AsianAmerican data 📊 🔗: bit.ly/4jZERlx The Ten Americas study from Institute for Health Metrics and Evaluation (IHME) reported that Asian Americans had the highest life expectancy, income & education. This framing masks disparities! 1/x

Another wonderful piece from Drs. James Wu | 吴简凡 MD and Edward Christopher "Chris" Dee, MD taking a deeper look at intersectionality and the Asian American community. 👏🏻

So proud of shriyagarg35 Khushi Kohli and team for this study of receipt of #palliative intent interventions focusing on #Hispanic #patients with #cancer 🙏 Drs Erin Feliciano, MD, MBA Daniel Gomez Puneeth Iyengar Dr. Brandon Mahal Yefri Baez, MD Kaitlyn Lapen and #team Memorial Sloan Kettering Radiation Oncology

Was finally able to get a hard copy of my JAMA Oncology piece entitled “Persons With Cancer Rather Than Cancer Patients—Semantics Matter,”

.Puneeth Iyengar and Edward Christopher "Chris" Dee, MD discuss the potential benefits and barriers to adopting hypofractionated radiation therapy. Learn more: bit.ly/45tnW7p

A powerful stance from The Lancet Global Health on why it is imperative we focus on protecting vulnerable gender diverse and transgender individuals’ health in multiple contexts. And so proud they are able to highlight our paper on global SGM cancer equity Edward Christopher "Chris" Dee, MD thelancet.com/journals/langl…

New computational tools enable scientists to comb through large datasets of books, paintings, music and other art forms to understand past people’s psyches. sciencenews.org/article/ai-cul…

Such a pleasure for our class Memorial Sloan Kettering Radiation Oncology to learn from Dr Anthony D'Amico, whose message of mentorship, family, love, and meaning are vital for us #radonc #physicians starting our last year of #residency 🙏 Kaitlyn Lapen @RoshalP Nikhil Mankuzhy, MD @JeffMeng0 @AlexGoglia

Thank you Dr Dr. Nina Niu Sanford and Dr Suntrea Hammer for helping us in #radonc demystify the work of our #pathology colleagues!! 🤩 #GIonc

🚨 GI Cancer Mortality to Double by 2050📊 ESMO GI 2025 shows sharp rise in deaths due to: 🔹 Colorectal: +103% 🔹 Pancreatic: +100% 🔹 Esophageal: +86% 🔹 Liver: +81% 🌍 Biggest increases in Asia & Africa 💡 Call to action: Early detection, access, equity. Time for GI oncologist

In The Lancet Oncology, we present "African self-sufficiency in cancer control" With recent cuts to foreign aid from the US, UK, France, and the Netherlands, we call for pan-#African collaboration in #cancer #control. Grateful to our global team! bit.ly/3Tm0tOc

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C) thelancet.com/journals/lanon… The phase 3 PACE-C trial compared early toxicity between moderately hypofractionated radiotherapy (MHRT) and stereotactic body